Over the years, as Sanofi and Regeneron’s Dupixent racked up new indications and approached the French pharma giant’s 10 billion euro peak sales goal, analysts had started …
We’re seeing victory laps these days during the Summer Olympic Games. Now it’s Pfizer’s turn. Three months after estimating 2021 revenues for its COVID-19 vaccine …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
